Latest Capital Raises News

Carnegie Clean Energy marked steady progress in Q3 2025, hitting key manufacturing milestones for its CETO wave energy system in Spain, securing €4 million in EU funding, and raising $2.1 million from shareholders to fuel commercialisation efforts.

Clara Resources upgrades the Ashford Coking Coal Project resource classification and raises $1.6 million to fund a critical drilling program, while reviewing strategic options for its Kildanga Nickel/Cobalt asset.

Avira Resources has secured a binding agreement to acquire the high-grade Mt Cattlin Gold Project and raised $2.5 million in firm commitments, positioning itself for significant exploration activity in Western Australia and Sweden.

Kairos Minerals has completed a $27 million placement and secured a landmark mineral rights agreement with Pilbara Minerals, significantly expanding its Mt York Gold Project drilling program and advancing exploration at Roe Hills.

Jade Gas Holdings has achieved continuous gas flow from two production wells and secured its first LNG sales agreement with Mongolia’s largest natural gas importer, UB Metan LLC. The company also raised $5 million to support its commercial operations.

ABx Group Limited reports strong progress in rare earth extraction and clean chemical production, backed by strategic investments and a recent $3 million capital raise.

Elevate Uranium has raised $25 million through a well-supported placement, boosting its cash reserves to nearly $44 million. The funds will accelerate its proprietary U-pgrade™ pilot plant and expand uranium resource drilling in Namibia and Australia.

Artrya Limited has completed the second tranche of its share placement, raising $14.7 million to advance its AI-powered Salix platform for coronary artery disease detection.

Golden Horse Minerals has raised A$35 million through a strongly supported placement to accelerate exploration and development at its Southern Cross Gold Project in Western Australia.

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug candidate NUZ-001 and strengthened its balance sheet with a $5.2 million capital raise. The company is now poised to enter the pivotal HEALEY ALS Platform Trial, marking a significant step forward in its neurodegenerative disease program.

Codeifai Limited reports a 10% revenue increase in Q3 2025 and completes due diligence on the QuantumAI Secure platform acquisition, signaling a strategic pivot into quantum-resilient fintech solutions.

Hawk Resources advances exploration with imminent drilling at five copper-gold targets in Utah and secures an option to acquire a major scandium project in Western Australia, supported by a $5 million placement.